FDA Inspection 1061622 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on Jun 19, 2018 in Lansing, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 19, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lansing, MI (United States)